Hypermethylation of exon 1 of p16(INK4a) was examined in tumour and plasma
DNA of a series of breast cancer patients. De novo methylation was observed
in the tumours of eight patients (23%), and in plasma DNA in five (14%) of
these eight patients. Our data show that de novo methylation of exon 1 of
p16(INK4a) can be demonstrated in plasma DNA of breast cancer patients, a f
act that provides additional evidence of the tumour-related origin of free
plasma DNA in cancer patients.